In this Book

summary
Today, when many parents seem reluctant to have their children vaccinated, even with long proven medications, the Salk vaccine trial, which enrolled millions of healthy children to test an unproven medical intervention, seems nothing short of astonishing. In Selling Science, medical historian Stephen E. Mawdsley recounts the untold story of the first large clinical trial to control polio using healthy children—55,000 healthy children—revealing how this long-forgotten incident cleared the path for Salk’s later trial. Mawdsley describes how, in the early 1950s, Dr. William Hammon and the National Foundation for Infantile Paralysis launched a pioneering medical experiment on a previously untried scale. Conducted on over 55,000 healthy children in Texas, Utah, Iowa, and Nebraska, this landmark study assessed the safety and effectiveness of a blood component, gamma globulin, to prevent paralytic polio. The value of the proposed experiment was questioned by many prominent health professionals as it harbored potential health risks, but as Mawdsley points out, compromise and coercion moved it forward. And though the trial returned dubious results, it was presented to the public as a triumph and used to justify a federally sanctioned mass immunization study on thousands of families between 1953 and 1954. Indeed, the concept, conduct, and outcome of the GG study were sold to health professionals, medical researchers, and the public at each stage. At a time when most Americans trusted scientists, their mutual encounter under the auspices of conquering disease was shaped by politics, marketing, and at times, deception. Drawing on oral history interviews, medical journals, newspapers, meeting minutes, and private institutional records, Selling Science sheds light on the ethics of scientific conduct, and on the power of marketing to shape public opinion about medical experimentation.

Table of Contents

  1. Cover
  2. restricted access Download |
  1. Half title, Series info, Title page, Copyright, Dedication
  2. p. 2
  3. restricted access Download |
  1. Contents
  2. pp. vii-viii
  3. restricted access Download |
  1. List of Illustrations
  2. pp. ix-x
  3. restricted access Download |
  1. Acknowledgments
  2. pp. xi-xii
  3. restricted access Download |
  1. List of Abbreviations
  2. pp. xiii-xiv
  3. restricted access Download |
  1. Introduction
  2. pp. 1-13
  3. restricted access Download |
  1. Chapter 1. Forging Momentum
  2. pp. 14-31
  3. restricted access Download |
  1. Chapter 2. Building Consent for a Clinical Trial
  2. pp. 32-52
  3. restricted access Download |
  1. Chapter 3. Marketing and Mobilization
  2. pp. 53-75
  3. restricted access Download |
  1. Chapter 4. The Pilot Study
  2. pp. 76-97
  3. restricted access Download |
  1. Chapter 5. Operation Marbles and Lollipops
  2. pp. 98-121
  3. restricted access Download |
  1. Chapter 6. The National Experiment
  2. pp. 122-142
  3. restricted access Download |
  1. Notes
  2. pp. 143-184
  3. restricted access Download |
  1. Bibliography
  2. pp. 185-206
  3. restricted access Download |
  1. Index
  2. pp. 207-210
  3. restricted access Download |
  1. About the Author
  2. restricted access Download |
  1. Further Series Titles
  2. restricted access Download |

Additional Information

ISBN
9780813574417
Related ISBN
9780813574394
MARC Record
OCLC
952070849
Pages
272
Launched on MUSE
2016-06-25
Language
English
Open Access
No
Back To Top

This website uses cookies to ensure you get the best experience on our website. Without cookies your experience may not be seamless.